Skip to Main Content

Paper Details

Sphingolipid Metabolic Pathway Impacts Thiazide Diuretics Blood Pressure Response: Insights From Genomics, Metabolomics, and Lipidomics.
J Am Heart Assoc
16
2017
C, HCTZ, N24:2 sphingomyelin, SPTLC3, SPTLC3 gene, SPTLC3 genomic region, Sphingolipid, Thiazide, clinicaltrials, hydrochlorothiazide, patients, rs6078905, sphingolipid, sphingomyelin, sphingomyelins
Author NameAffiliation
Amber L BeitelsheesUniversity of Maryland
Stephen T TurnerCollege of Medicine, Mayo Clinic
Eric BoerwinkleHuman Genetics Center and Institute for Molecular Medicine, University of Texas Health Science Center
Eric BoerwinkleHuman Genetics Center and Institute for Molecular Medicine, University of Texas Health Science Center
Alison A Motsinger-ReifBioinformatics Research Center, North Carolina State University
Oliver FiehnUniversity of California at Davis
Oliver FiehnKing Abdulaziz University
Oliver FiehnUniversity of California at Davis
Oliver FiehnKing Abdulaziz University
Rhonda M Cooper-DeHoffDepartment of Pharmacotherapy and Translational Research and Center for Pharmacogenomics, University of Florida
Julie A JohnsonDepartment of Pharmacotherapy and Translational Research and Center for Pharmacogenomics, University of Florida
  • 1 - 11

Datasets

Release 1.2